Navigation Links
Survivors of childhood polio do well decades later as they age

Mayo Clinic researchers have found that years after experiencing childhood polio, most survivors do not experience declines greater than expected in their elderly counterparts, but rather experience only modest increased weakness which may be commensurate with normal aging.

"Other researchers have suggested that polio is a more aggressive condition later in life, but we've actually found it to be relatively benign," says Eric Sorenson, M.D., Mayo Clinic neurologist and lead study researcher. "Our results suggest that polio survivors may not age any differently than those in the normal population -- they're not doing too badly compared to their peers. This tells us that the cause for the decline in muscle strength in polio survivors may be aging alone."

Polio is a contagious, viral illness that peaked in the United States in 1952, when 3,000 people died of the disease. Mass immunizations in the mid-1950s began to slow the spread of the disease, and the last case of polio not caused by a vaccine occurred in the United States in 1979. The three major types of polio include spinal polio, a paralytic polio that attacks nerve cells in the spinal cord; bulbar polio, in which the virus attacks motor neurons in the brainstem; and bulbospinal polio, a combination of spinal and bulbar polios. The effects of polio run the gamut from a complete return to normal function to paralysis of limbs to acute death. Following the illness, most patients are worried about their long-term prognoses, according to Dr. Sorenson.

To conduct this study, the researchers randomly selected a group of 50 polio survivors from the general population of Olmsted County, home of Mayo Clinic, and followed them for 15 years. The average age of participants at the study's start was 53, and the patients were an average of 40 years past their childhood experience with polio. The researchers measured strength and loss of neurons at the beginning of this period, and then again five a
'"/>

Source:Mayo Clinic


Page: 1 2

Related biology news :

1. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
2. Emergence of cancer as major cause of childhood death in developing countries is not being adequately addressed
3. UCLA researchers identify key enzyme linked to childhood blindness
4. Large-scale genomics project will hunt genes behind common childhood diseases
5. Mother knows best: Plant knowledge key to childhood health in remote Amazon
6. 20-year study shows significant rise in childhood obesity, especially among girls
7. New study challenges critical period in childhood vision development
8. First clinical trial of gene therapy for childhood blindness
9. UN pours polio vaccine into Yemen amid outbreak
10. Billions of dollars saved in US by polio vaccination
11. Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Survivors childhood polio well decades later they age

(Date:6/23/2015)... , June 23, 2015   Valencell, ... announced the results of a recent study that ... on the wrist during activity. In a study ... was compared along with the Apple Watch against ... measuring heart rate during activity. The study demonstrated ...
(Date:6/17/2015)... GERMANTOWN, Maryland , June 17, 2015 ...   Produktlinie mit DNA-Tests verbessert den Analyseprozess und ... QGEN ; Frankfurt Prime Standard: QIA) hat heute in ... Produktlinie Investigator ® für ... Die neuen Kits zur Erstellung genetischer Fingerabdrücke bieten eine ...
(Date:6/16/2015)... June 16, 2015 /CNW Telbec/ - handyem Inc. ... around the incorporation of handyem,s HPC-150 portable flow ... the Mo-POD™. This unprecedented model of mobile laboratory ... at the Pennsylvania Convention ... 15 th to 18 th 2015. ...
Breaking Biology News(10 mins):Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3
... CLEAR Program is Back and Oberthur Technologies Remains a Key Partner -- CHANTILLY, Virginia, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
... SEATTLE, Wash. November 18, 2010 The Paul ... advance important neuroscience and cellular engineering research. The Allen ... and laboratories in Washington, California, Massachusetts and New York. ... paid over three years. "A year ...
... teaching space and Earth sciences, there,s a world of information ... K-12 teachers to bring it into the classroom. The ... grant to professors Paul Ruscher and Alejandro Gallard for a ... a series of courses to be offered to undergraduate and ...
Cached Biology News:The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 2The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 3The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 4The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 5The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 6The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 7The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 8The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 9First Allen Distinguished Investigators named 2First Allen Distinguished Investigators named 3FSU researchers helping K-12 teachers bring science down to Earth 2
(Date:6/30/2015)... June 30, 2015  Today, Americord Registry, one of the ... Andrew Horne , a partner at Kirkland & Ellis LLP, ... Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are ... Board," says Martin Smithmyer , CEO of Americord. "He ... career that will assist Americord,s growth and vision." ...
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of shares ... outstanding common shares (including shares of unvested restricted stock). On June 29, 2015, the ... price of Cryo-Cell’s shares reported on the OTCBB was $2.29 per share. , The ...
(Date:6/30/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company focused on the development of autologous cell ... Phase 1/2 clinical trial of RCT-01, being tested ... has been enrolled and their tissue biopsy sent ... is comprised of non-bulbar dermal sheath (NBDS) cells ...
(Date:6/30/2015)... ... June 30, 2015 , ... Cannavoices , Inc., ... unprecedented digital video and broadcast initiative. Produced by filmmakers, the multi-platform initiative aims ... legal medical cannabis stories ever assembled. , Cannavoices profiles Advocates, Patients, Entrepreneurs, ...
Breaking Biology Technology:Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3
... Wednesday, October,22, 2008, Wyeth (NYSE: WYE ) will ... will hold a one-hour conference call with,research analysts at ... and others may listen to the call live or ... be accessed by visiting our website,at http://www.wyeth.com ...
... Coleman to Lead Scientific Operations, NAPLES, Fla., ... ETHANOL(TM), the most advanced third generation biofuels,technology, today ... as Chief,Science Officer. Dr. Coleman, currently the Vice-Principal ... has over 20 years of,experience in the fields ...
... MEETING, Pa., Sept. 8 /Xinhua-PRNewswire-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: ... Company will present at the following conference:, ... the Grand Hyatt Hotel in Beijing on ... present at 10:20 AM local time. ...
Cached Biology Technology:Algenol Biofuels Appoints Chief Science Officer 2BMP Sunstone Announces Participation in September Investor Conference 2
MOUSE ANTI DUCK IgY LIGHT CHAIN...
Kit for Detection of Mitochondrial Membrane Potential...
For the quantitative determination of canine Interleukin 10,(IL-10) concentrations in cell culture supernates, canine serum,and plasma....
...
Biology Products: